NCT05508932Recruiting
Atrial Fibrillation in Beta-Thalassemia
Source: ClinicalTrials.gov · Last updated 24 Feb 2026
Brief summary (registry, in English)
The study aims to evaluate the clinical, laboratory and instrumental differences that exist between beta-thalassemia patients with atrial fibrillation and those not affected by arrhythmia.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 350 (estimated)
- First submitted
- 16 Aug 2022
- Start date
- 1 Sept 2022
- Primary completion date
- 1 Jun 2032
- Lead sponsor
- University Hospital of Ferrara
- Diseases
- Thalassaemia, Atrial fibrillation
- NCT number
- NCT05508932
What you commit to
- Study type: Observational
- Planned participants: 350
- From 1 Sept 2022 to the primary completion date, 1 Jun 2032
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Age
- Age \<18 years;
Other
- State Of pregnancy;
- Inability to give informed consent.
Who the study is looking for
- Transfusion-dependent Beta-thalassemia;
- Follow-Up at the Cardiology Unit of the University Hospital of Ferrara;
- Electrocardiogram performed;
- Echocardiogram performed.
Age in the registry: 18 years to - · Sex: All
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Matteo Bertini Coordinator of this site? Confirm its status | Ferrara | Italy | Recruiting |
Related publications
This page is information, not medical advice. Discuss any trial with your doctor.